לוקרין פ.ד.ס דפו 3.75 מ"ג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 3.75 מ"ג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 3.75 mg/vial - suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.

לוקרין פ.ד.ס דפו 11.25 מ"ג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 11.25 מ"ג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate 11.25 mg - powder for suspension for injection - leuprorelin - endometriosis prostatic cancer treatment of uterine fibroids for a period of up to six months. treatment of breast cancer in pre- and peri - menopausal women in whom hormone therapy is specified.

ורהסיל ישראל - עברית - Ministry of Health

ורהסיל

omrix biopharmaceuticals - human fibrinogen; human thrombin - human thrombin 500 iu / 1 ml; human fibrinogen 80 mg / 1 ml - human fibrinogen

תרומביקסיל ישראל - עברית - Ministry of Health

תרומביקסיל

omrix biopharmaceuticals - calcium chloride 5.6 - 6.2 mg; human thrombin 800 - 1200 iu - solution - thrombin - as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standart surgical techniques is ineffective or impractical.

זמפלר 1 מיקרוגרם ישראל - עברית - Ministry of Health

זמפלר 1 מיקרוגרם

abbvie biopharmaceuticals ltd, israel - paricalcitol - קפסולות - paricalcitol 1 mcg - paricalcitol - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

אומר-יג-אם % 5 ישראל - עברית - Ministry of Health

אומר-יג-אם % 5

omrix biopharmaceuticals - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 50 mg/ml mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy * primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinemia or hypogammaglobulinemia) * myeloma or chronic lymphocytic leukemia (cll) with severe secondary hypogammaglobulinemia and recurrent infections. * children with congenital aids and recurrent infections - immunomodulation * idiopathic thrombocytopenic purpura (itp) * guillain barre syndrome * kawasaki disease - allogenic bone marrow transplantation

לוקרין פ.ד.ס  דפו 11.25 מג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 11.25 מג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin

לוקרין פ.ד.ס  דפו 11.25 מג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 11.25 מג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 11.25 mg - leuprorelin

לוקרין פ.ד.ס דפו 3.75 מג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 3.75 מג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 3.75 mg - leuprorelin

לוקרין פ.ד.ס דפו 3.75 מג ישראל - עברית - Ministry of Health

לוקרין פ.ד.ס דפו 3.75 מג

abbvie biopharmaceuticals ltd, israel - leuprorelin acetate - leuprorelin acetate 3.75 mg - leuprorelin